Abstract
Cas4 proteins, a core protein family associated with the microbial system of adaptive immunity CRISPR, are predicted to function in the adaptation step of the CRISPR mechanism. Here we show that the Cas4 protein SSO0001 from the archaeon Sulfolobus solfataricus has metal-dependent endonuclease and 5' to 3' exonuclease activities against single-stranded DNA, as well as ATP-independent DNA unwinding activity toward double-stranded DNA. The crystal structure of SSO0001 revealed a decameric toroid formed by five dimers with each protomer containing one [4Fe-4S] cluster and one Mn2+ ion bound in the active site located inside the internal tunnel. The conserved RecB motif and four Cys residues are important for DNA binding and cleavage activities, whereas DNA unwinding depends on several residues located near the [4Fe-4S]-cluster. Our results suggest that Cas4 proteins might contribute to the addition of novel CRISPR spacers through the formation of 3'-DNA overhangs and to the degradation of foreign DNA.
Keywords: CRISPR interference, Cas4, exonuclease, RecB motif, [4Fe-4S] cluster
INTRODUCTION
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and associated proteins (Cas) comprise a novel prokaryotic immune system, which resembles eukaryotic RNA interference and protects microbial cells from invading viruses and plasmids1–3. In the first step of CRISPR mechanism (“adaptation”), Cas proteins recognize foreign DNA and incorporate short sequences (25–50 nt) of this DNA (protospacers) into the host chromosome as new spacers. During the “expression”step, these viral-specific spacers are transcribed and processed by other Cas proteins to produce short CRISPR RNAs (crRNAs). In the last step (“interference”), the crRNAs in complex with different Cas proteins specifically recognize and degrade foreign DNA or RNA4–8.
Cas proteins can be organized into as many as 45 protein families with predicted nuclease, helicase, nucleic acid binding, or unknown activities1,9. Six families of Cas proteins (Cas1 to Cas6) form the core group, which are present in most CRISPR-harbouring genomes. Based on the composition of Cas proteins in microbial genomes, the CRISPR-Cas systems have been classified into three major types: I, II, and III. The type I system is the most widespread and is divided into six sub-types (I-A to I-F) on the basis of sub-type specific genes2. The type I system includes the Cas3 protein and complexes of subtype-specific Cas proteins involved in crRNA processing and recognition of DNA targets6,10. The CRISPR type II system contains the large multi-domain protein Cas9 instead of Cas3, whereas the type III system includes the Cas6-RAMP module (Cmr or Csm).
The least understood step of CRISPR interference is adaptation, which has been proposed to involve the recognition of foreign DNA (self/non-self) and PAM sequences, excision of protospacers from the invader DNA and incorporation of them into CRISPR loci performed by the core proteins Cas1, Cas2, Cas4 and the subtype II-A specific Csn21,3,5,11,12. Cas4 proteins have been predicted to function in the adaptation step, because their genes are usually associated and sometimes fused to cas1 genes, and the Thermoproteus tenax Cas4 protein forms a complex with Cas1 and Cas2 proteins13. The sequences of Cas4 proteins contain a RecB-like nuclease motif and four conserved Cys residues, which are predicted to coordinate an Fe-S cluster. Based on sequence, Cas4 proteins belong to RecB-like nucleases, which are related to the λ exonuclease and other enzymes from the restriction endonuclease-like superfamily1,14. The multifunctional E. coli RecBCD and Bacillus subtilis AddAB helicase-nuclease complexes represent the main engine of DNA recombination and repair, which involve unwinding of DNA duplex and formation of 3'-ssDNA tails15–17. In addition, the RecBCD complex contributes to the degradation of foreign DNA entering the microbial cell15.
The crenarchaeon S. solfataricus contains a complex CRISPR system with two sub-systems (types I-A and III-B) organized into six CRISPR loci (A-F) with 52 Cas genes18,19. The S. solfataricus genome encodes five Cas4-like proteins which share low sequence similarity (15 to 30% sequence identity) and belong to DUF83 (SSO0001, SSO1392, SSO1449) and DUF911 (SSO1391, SSO1451) (Supplementary Fig. S1). Recently, the purified SSO0001 has been shown to possess a 5′ to 3′ exonuclease activity20.
Here, we demonstrate that the S. solfataricus Cas4 protein SSO0001 exhibits metal-dependent endonuclease and 5'→3' exonuclease activities against ssDNA, as well as ATP-independent unwinding activity toward dsDNA. Crystal structure of SSO0001 revealed a toroidal decameric complex with each protomer containing a [4Fe-4S] cluster and a Mn2+ ion. The DNA binding and cleavage activities are dependent on the conserved Cys and RecB motif residues, whereas the DNA unwinding activity is associated with residues located near the [Fe-S]-cluster.
RESULTS
Nuclease activity of Cas4 proteins
The purified Cas4 proteins SSO0001 and SSO1391 from S. solfataricus and Pcal_0546 from Pyrobaculum calidifontis exhibited a brown color indicating the presence of functional Fe-S clusters (Fig. 1a). Their absorption spectra showed the presence of a broad shoulder at 380–420 nm typical of 4Fe-4S cluster containing proteins (Fig. 1a). Nuclease assays using the 5'- and 3'-[32P]-labeled linear ssDNA revealed the presence of high metal-dependent nuclease activity in all three proteins (Fig. 1b–d) including SSO1391 which was reported to be catalytically inactive in a previous work20. The nuclease activity of SSO0001 was maximal in the presence of Mg2+ or Mn2+ (5 mM), KCl (20 – 100 mM), at alkaline pH (9 – 10), and at high temperatures (65 – 70 °C) (Supplementary Fig. S2). In contrast to the HNH-like and GIY-YIG-like nucleases, Ca2+ did not support the nuclease activity of SSO0001 (Supplementary Fig. S2a). The rates of cleavage of ssRNA and dsDNA with blunt ends by SSO0001 were approximately 20 times and 200 times lower, respectively, compared to ssDNA (Fig. 2b, Supplementary Fig. S2d).
Figure 1.
Absorption spectra and nuclease activity of purified Cas4 proteins. (a), Absorption spectra of SSO0001 (green line), Pcal_0546 (red line), and SSO1391 (blue line). The insets show the photo of the vial with the concentrated purified protein. Cleavage of ssDNA: (b), SSO0001; (c), Pcal_0546; (d), SSO1391. The 3'- or 5'-[32P]-labelled ssDNA was incubated without protein (lane C) or with 8 nM SSO0001 (A), 493 nM Pcal_0546 (B), or 250 nM SSO1391 (wt or E195A mutant) (C) for the indicated time (60 min for mutant) at 45 °C and analyzed by denaturing gel electrophoresis. (e, f, g), Endonuclease assays: cleavage of the circular ssDNA of M13mp18. The M13mp18 ssDNA (5 nM) was incubated at 45 °C without protein addition (lane C) or in the presence of 8 µM SSO0001 (45 min) (e), 0.4 µM Pcal_0546 (20 min) (f), or 0.5 µM SSO1391 (45 min) (g), and the reaction products were analyzed by agarose gel electrophoresis and SYBR Green staining. Lanes EndoV and EDTA represent control experiments with Endonuclease V or 5 mM EDTA.
Figure 2.
Binding and cleavage of dsDNA by SSO0001. (a), gel-shift assays. The indicated amounts of SSO0001 were incubated with ssDNA, dsDNA with blunt ends, dsDNA with 5'-overhangs, or dsDNA with 3'-overhangs, and the reactions were analyzed by native PAGE. (b, c), Cleavage of dsDNA with blunt ends, 5'-overhangs, 3'-overhangs, or the splayed arm substrate (18 nM SSO0001) incubated for 15 min (b) or as indicated (c) at 45 °C. In all substrates, one strand is [32P]-labelled at the 3'-end (indicated by asterisks), and the length of ssDNA overhangs is indicated on the substrate models (nt). Lanes C show incubation without SSO0001 addition.
With the 5'-labeled ssDNA as substrate, SSO0001 produced mononucleotides as products, whereas the 3'-labeled substrate was cleaved with the formation of a series of oligonucleotides with the shortest product containing four nucleotides (Fig. 1b). These results confirm that SSO0001 is a 5' → 3' exonuclease that cleaves one nucleotide at a time from the 5'-end of the substrate. The short oligonucleotides (17 nt) were cleaved by SSO0001 faster than longer substrates (62 nt) (Supplementary Fig. S2j), whereas phosphorylation or biotinylation of substrates at the 5'-terminus had no effect on activity (Supplementary Fig. S2h, i). The 5' to 3' exonuclease activity was also observed in the Cas4 protein Pcal_0546 (also DUF83), whereas SSO1391 (DUF911) produced a range of cleavage products with both substrates indicating that it cleaves ssDNA in both directions (5' → 3' and 3' → 5') (Fig. 1c and 1d, respectively). The three proteins also showed Mn2+-dependent endonuclease activity with circular ssDNA of the M13mp18 phage as a substrate (Fig. 1e–g), but no activity against circular dsDNA (Supplementary Fig. S3a). Interestingly, the E. coli RecB nuclease domain is able to cleave ssDNA with dual polarity and endonucleolytically, whereas the RecB nuclease domain of the B. subtilis AddB is a 5' to 3' exonuclease17,21. Thus, our work together with the previous report on SSO000120 has demonstrated that the CRISPR-associated RecB-like proteins represent a diverse group of exonucleases, which can cleave ssDNA in one or both directions and also exhibit endonuclease activity against ssDNA.
Most known nucleases cleave the phosphodiester bond with the formation of 5'-phosphates and 3'-OH groups22. To determine the phosphodiester bond cleavage site of SSO0001, we carried out two reactions using the unlabeled ssDNA as substrate and T4 polynucleotide kinase (PNK): direct phosphorylation of cleavage products at 5'-end (requires a 5'-hydroxyl) and phosphate exchange reaction at 5'-end (requires a 5'-phosphate end). The results show high product labelling in the PNK phosphorylation reaction and no labelling in the PNK exchange reaction suggesting the absence of phosphate at the product 5'-end (Supplementary Fig. S3d). These results were confirmed using an unlabeled poly-dC10 ssDNA substrate and a liquid chromatography-mass spectrometry analysis (LC-MS) of the cleavage products of the wild type SSO0001 and its inactive mutant D99A (Supplementary Fig. S3e). Thus, SSO0001 cleaves ssDNA substrates with the formation of products containing 5'-hydroxyls and 3'-phosphates. In contrast, the characterized RecB-like nucleases and λ exonuclease have been shown to generate the products with 5'-phosphates and 3'-hydroxyls23,24 suggesting that these enzymes and SSO0001 might use different catalytic mechanisms.
SSO0001 exhibits ATP-independent DNA unwinding activity
Further biochemical characterization of Cas4 proteins was focused on SSO0001, since we solved its crystal structure. In electrophoretic mobility shift assays, the purified SSO0001 showed strong binding to ssDNA (42 nt) (Fig. 2a). With dsDNA substrates, detectable binding was observed only for substrates containing 5'-overhangs (10 nt), whereas no significant binding was observed to dsDNA with 3'-overhangs or blunt ends. This is consistent with the 5' to 3' polarity of ssDNA cleavage by SSO0001 (Fig. 1b). In nuclease assays, SSO0001 was able to cleave these dsDNA substrates, although with lower rates than ssDNA (Fig. 2b). With dsDNA substrates, the highest activity was observed against the dsDNA with 5'-overhangs and the lowest activity toward dsDNA with blunt ends. These results also suggest the presence of DNA unwinding activity in SSO0001. This was confirmed using the splayed arm duplex substrates, which are the intermediates of DNA recombination and integration and also might represent a potential intermediate of CRISPR spacer acquisition. Splayed arm structures are known substrates for RecB-like nucleases and are cleaved by them through a combination of exonuclease, endonuclease, and ATP-dependent helicase activities15. Two types of splayed arm substrates were used: containing both dsDNA (20 nt) and ssDNA (21 nt) areas with a [32P]-label located at the 3'-end of the bottom (in the dsDNA area) or top (in the ssDNA area) strands (Fig. 2c, S3b). The time point experiments with the first substrate revealed the formation of a series of products with different lengths with the transitional accumulation of the 20 nt long products suggesting that the cleavage of labeled strand by SSO0001 was slowed upon reaching the substrate duplex (Fig. 2c). Longer incubation times (25 min) resulted in the formation of short products (1–4 nt), which can be produced only after complete unwinding of DNA duplex. The formation of short products was also observed with the second substrate containing the label at the 3'-end of the top strand, but this required longer incubation times consistent with the requirement to unwind and degrade the unlabeled strand first (Fig. 2c). With a series of splayed arm substrates with different arm lengths (5 to 30 nt), SSO0001 showed higher activity toward substrates with short arms (5–15 nt) (Supplementary Fig. S2k). ATP addition had no effect on the unwinding and cleavage of splayed arm substrates by SSO0001 suggesting that SSO0001 is an ATP-independent DNA unwinding enzyme (Supplementary Fig. S2l). Thus, our results indicate that in addition to endonuclease and 5' → 3' exonuclease activities toward ssDNA SSO0001 also exhibits the unwinding activity against dsDNA.
SSO0001 activity against CRISPR-related substrates
The CRISPR adaptation step has been proposed to involve the recognition of the leader, repeat, and PAM sequences and the formation of dsDNA breaks and 3′ ssDNA overhangs3,5,12,20. To determine if SSO0001 exhibits a preference for substrates containing the S. solfataricus CRISPR sequences, we analyzed its activity against 14 ssDNA substrates (60–63 nt) containing various combinations of the repeat, spacer-1, and leader sequences from the S. solfataricus CRISPR locus B, which is the biggest (and probably most active) CRISPR locus in this organism (Supplementary Table S1). SSO0001 cleaved all these substrates with some preference for the repeat-spacer-repeat substrate, which also supported higher activity of SSO0001 in DNA binding assay suggesting that this protein might exhibit some level of sequence preference (Fig. 3a, b). It has been shown that the Sulfolobus CRISPR systems preferentially target protospacers located at the 3'-end of the PAM sequences CCN, TCN, and GTN or at the 5'-end of the PAM NGG19,25. We designed 32 ssDNA substrates (CRISPR-A spacer-1, 41 nt) containing these PAMs located at the substrate 5'-end, in the middle, or at the 3'-end, as well as 27 substrates with non-PAM sequences (ACA, CAA, GAA) (Supplementary Table S1). SSO0001 showed similar cleavage and binding activities with both PAM and non-PAM substrates suggesting that the purified SSO0001 is not strictly specific to the PAM-containing ssDNA substrates in vitro (Fig. 3c, 3d; Supplementary Fig. S4, S5). The effect of PAMs on the DNA unwinding activity of SSO0001 was tested using several splayed arm substrates (42 nt) containing the sequences of the S. solfataricus CRISPR-B leader or spacer-1 and the TCC PAM placed at the 5'-end, in the middle, or 3'-end of the bottom strand, which was 3'-[32P]-labeled (Fig. 3e; Supplementary Fig. S3c). SSO0001 exhibited different levels of unwinding and cleavage activities against these substrates with the absence of the noticeable correlation with the presence or location of PAM (Fig. 3e; Supplementary Fig. S3c). Thus, our results are consistent with a lack of significant sequence preference in SSO0001 toward the substrates containing the S. solfataricus PAMs in DNA binding and cleavage reactions in vitro.
Figure 3.
Cleavage and binding of CRISPR-related substrates by SSO0001. Cleavage (a) and binding (b) of ssDNA containing various combinations of sequences from the S. solfataricus CRISPR-B: L-R-S, leader (L; 18 nt), repeat (R; 25 nt), and spacer-1 (S; 17 nt); R-S-R, the spacer-1 fragment (10 nt) flanked by the repeat-1 sequences (25 nt each); S-R-S, repeat-1 (25 nt) flanked by the spacer-1 fragments (17 nt and 18 nt); L-R, the leader fragment (35 nt) with repeat-1 (25 nt); R-S, repeat-1 (25 nt) with spacer-1 (38 nt); S-R, spacer-1 (38 nt) with repeat-1 (25 nt). Cleavage (c) and binding (d) of ssDNA containing different S. solfataricus PAM (TCA, TCC) or non-PAM (GAA) sequences at the 5'-end, center, or 3'-end of the S. solfataricus CRISPR-A spacer-1. The sequence and position of PAMs are indicated by the letters on the substrate models. (e), Cleavage of splayed arm substrates containing the S. solfataricus CRISPR-B leader sequence with varying positions of the TCC PAM on the labelled strand. In all experiments, the 3'-[32P]-labelled substrates were incubated with the indicated amounts of SSO0001 at 45 °C for 15 min (lanes C show incubation without SSO0001 addition).
The crystal structure of SSO0001 reveals bound Mn2+ and a 4Fe-4S cluster
Purified SSO001 was crystallized and produced brown-coloured crystals suggesting the presence of intact Fe-S clusters (Fig. 4a). The structure of the seleno-methionine substituted protein was solved at 2.35 Å resolution (Supplementary Table S3) and revealed the core αβα protein domain capped by a small, mostly α-helical sub-domain (Fig. 4b). The core domain contains the V-shaped β-sheet, which is surrounded by α-helices α1, α2, α3, α4, and α5 creating a large elongated opening (12–24 Å) on one side and a smaller round hole (9 Å) on the other side. The small sub-domain is formed by three helices (α3, α8, and α9) and the long loop 177–186. This domain coordinates a cubane-like [4Fe-4S] cluster with the typical Fe-Fe (2.9 Å) and Fe-S (2.1 Å) distances (Fig. 4b, 5d). The [4Fe-4S] cluster is coordinated by the side chains of four Cys residues (Cys32, Cys188, Cys191, Cys197), which are conserved in all Cas4 proteins and AddB-like nucleases (Supplementary Fig. S1). Thus, the SSO0001 structure confirms that Cas4 proteins are members of a class of “iron-staple” nucleases, which also include AddB and Dna217,26.
Figure 4.
Crystal structure of SSO0001. (a), A photo of the SSO0001 crystal (~300×300×50 µm). (b), Overall structure of the SSO0001 protomer: two views related by a 180∞ rotation. The protein core domain is coloured in red (helices) and blue (strands), whereas the Fe-S cluster binding sub-domain is coloured in green. The [4Fe-4S]-clusters are shown as orange and yellow balls, whereas the position of the active site is indicated by the Mn2+ ion (magenta balls). (c), Two views of the SSO0001 "dimer" related by a 90° rotation. The two protomers are coloured in red and blue, whereas their Fe-S cluster coordinating sub-domains in green.
Figure 5.
Quaternary structure of SSO0001. (a), Two views of the decameric toroid related by 90° rotation: a surface presentation. The protomers are shown in different colors. (b), Two views of the decameric toroid with protomers shown as semi-transparent ribbons to demonstrate the position of [4Fe-4S]-clusters (orange and yellow balls) and Mn2+ (black balls). (c), Schematic diagram showing the arrangement of protomers in the pentameric ring and distances between Fe-S clusters and Mn2+ ions. (d), Coordination of [4Fe-4S] cluster in SSO0001 and inter-atomic distances (in Å). The Cys side chains are shown as sticks, the Fe atoms as orange balls, and S2− as yellow balls.
A Dali search27 for the SSO0001 structural homologues identified several exonucleases including the alkaline exonuclease LHK-Exo from Laribacter honkongensis (PDB code 3SZ4; Z-score 11.9, root mean square deviation 3.2 Å), λ exonuclease (PDB 3SLP; Z-score 11.0, r.m.s.d. 3.2 Å), and the C-terminal RecB-like nuclease domain of the B. subtilis AddAB helicase-nuclease complex (PDB 3U44, Z-score 10.6, r.m.s.d. 3.3 Å). The nuclease domain of the E. coli RecE was also highly similar to SSO0001 (3H4R; Z-score 10.5, r.m.s.d. 3.7 Å), whereas the E. coli RecB nuclease domain showed lower similarity (1W36; Z-score 6.9, r.m.s.d. 3.9 Å). All these enzymes are metal-dependent 5' to 3' exonucleases that bind to dsDNA ends and processively digest the 5'-strand to produce long 3'-overhangs12,16,17,28,29.
SSO0001 protomers form decameric toroids
The final model of SSO0001 revealed ten protomers assembled as a pentamer of “dimers” creating a toroidal structure (105 Å × 67 Å) with a large central channel (55 Å diameter) (Fig. 5). The tightly sealed “dimers” are formed through the interactions between the two long helices α5 with the contribution from the residues located on the α1 helix and the β-strands β6 and β7 (Fig. 4c). Analysis of the crystal contacts in the SSO0001 structure using quaternary prediction server PISA also suggested a decameric state arranged as a pentamer of “dimers”. The decameric state of SSO0001 in solution was experimentally confirmed using analytical ultra-centrifugation (243,138 Da or 9.5 protomers; predicted molecular mass for the His-tagged protomer 25.6 kDa) and size-exclusion chromatography (216–268 kDa or 9–10.7 protomers). The SSO0001 toroid is formed by five vertically positioned and slightly twisted “dimers” creating a complex with two pentameric rings with D5 symmetry (Fig. 5). The C-terminal part of each protomer coordinates a [4Fe-4S] cluster and also interacts with two protomers from a neighbour “dimer” suggesting that the intact state of the Fe-S cluster might be important for the maintenance of the SSO0001 toroid. This is supported by a gel-filtration analysis of the oligomeric state of the SSO0001 Cys mutants (Cys32A, Cys188A, Cys191A, and Cys197A), which showed no brown color after purification and existed as a mixture of high molecular weight aggregates (385–400 kDa; 58–73%), pentamers (117–123 kDa; 20–30%), and monomers (27–29kDa; 7–14%) in solution (Fig. S3f).
SSO0001 active site is located in a tunnel
The position of the SSO0001 active site is indicated by the location of a metal ion (identified as Mn2+ using an X-ray fluorescence analysis), which is bound at the bottom of the elongated opening (between α5 and β5) close to the residues of the RecB-like sequence motif (Asp99, Glu113, Lys115, and Tyr148) (Fig. 6, Supplementary Fig. S6). In the SSO0001 toroid, all ten active sites are exposed to the interior side of the central channel, where the Fe-S clusters are located and whose surface is dominated by positively charged residues (Fig. 6, Supplementary Fig. S7). The opposite side of the SSO0001 protomers (exposed to the external side of the ring) has a predominantly negatively charged surface with small portals (Supplementary Fig. S7). Inside the SSO0001 protomer, the two openings are connected by the internal tunnel with ~ 10–12 Å diameter accommodating the Mn2+ ion (Fig. 6a). Compared to the λ exonuclease trimeric and RecE tetrameric rings, the SSO0001 toroid has a much larger central channel and is composed of two pentameric rings.
Figure 6.
The internal tunnel and active site of SSO0001. (a), Three views of the internal tunnel related by 90° rotation: from the toroid interior, an axial slice through the "dimer", and from the toroid exterior. The protein is shown in surface charge presentation with a blue (positively charged) to red (negatively charged) gradient and low degree transparency to reveal the position of Mn2+ (shown as magenta coloured balls). For clarity, only one tunnel is shown, and several charged residues are labelled to indicate their positions in different images. Electrostatic potential is indicated: (−25kTe-1 in red; 25kTe-1 in blue). (b), Close-up view of the SSO0001 active site showing the position of the Mn2+ ion (magenta-coloured ball), [4Fe-4S] cluster (orange and yellow balls), and the active site residues (shown as sticks) along a SSO0001 ribbon (grey).
The Mn2+ ion is located 20 Å away from the [4Fe-4S]-cluster and is coordinated by the side chains of conserved or semi-conserved residues His62 (2.3 Å), Asp99 (2.1 Å), Glu113 (2.1 Å), as well as the main chain carbonyl oxygen of Ile114 (2.1 Å) (Fig. 6b, Supplementary Fig. S6). Similar coordination of the metal ion was found in the λ exonuclease (Asp119, Glu129, and the backbone carbonyl of Leu130), E. coli RecB (His956, Asp1067, Asp1080, and the backbone carbonyl of Tyr1081), and E. coli RecE (His652, Asp748, Asp759, and the backbone carbonyl of Val760)16,30,31 (Supplementary Fig. S8). In SSO0001, Asp99 and Glu113 are part of the RecB motifs II and III, which also include the closely located Lys115 (motif III), Gln131, and Tyr135 (QxxxY motif) (Fig. 6b, Supplementary Fig. S1). Based on the SSO0001 structure, its RecB motif I residue is Glu78 (7.1 Å from the motif II Asp99), which is located near the exit from the internal channel and might contribute to product release (Fig. 6). The bottom part of the active site (between Mn2+ and Fe-S cluster) is occupied by the side chains of semi-conserved Arg31, Arg35, His127, His128, and Trp186 representing the potential binding site for a nucleic acid substrate, whereas the closely located Lys189 and Tyr190 might form a wedge structure involved in DNA strand separation (Fig. 6a).
Site-directed mutagenesis and potential catalytic mechanism of SSO0001
The four SSO0001 mutant proteins with conserved cysteines mutated to Ala (C32A, C188A, C191A, and C197A) produced colorless preparations, whose gel-filtration profiles showed the formation of various protein aggregates (Supplementary Fig. S3f). These mutant proteins were inactive in both binding and cleavage of ssDNA and splayed arm substrate indicating that the Fe-S cluster domain contributes to the stabilization of the SSO0001 active site (Fig. 7). In addition, the Fe-S cluster domains are oriented toward the central channel of the SSO0001 toroid providing a potential “wedge” structure for DNA strand separation (Fig. 5b). Similarly, alanine replacement of the Fe-S cluster coordinating cysteines of AddB eliminated the ability of this protein to bind duplex DNA26. In SSO0001, a strong negative effect of mutation on both substrate binding and cleavage was also observed in the K115A and Y148A proteins, whereas D99A and E113A showed significant binding, but very low or no nuclease activity confirming the importance of Mn2+ coordination and RecB motif residues for nuclease activity of SSO0001 (Fig. 7). The absence of nuclease activity in the SSO0001 D99A protein was also reported by Zhang et al.20. The H62A and H128A proteins retained high nuclease activity against ssDNA, but showed reduced ssDNA binding suggesting that these residues contribute to substrate coordination. The mutant proteins H127A, Q131A, and Y135A exhibited both significant DNA binding and nuclease activity against ssDNA (Fig. 7). Interestingly, the mutant proteins E113A and Y148A appear to be affected in both activity and ability to cleave short ssDNA, as they produced only a limited number of long products and no short products (Fig. 7). In the SSO0001 structure (Fig. 6b), the highly conserved Tyr148 is positioned close to the catalytic Lys115 (motif-III) and likely contributes to the coordination of the 5'-DNA strand in the active site. In addition, the R31A, R35A, H127A, H128A, W186A, K189A, and Y190A proteins retained high nuclease activity against ssDNA with the formation of short products, but they were unable to produce short products from the splayed arm substrate confirming our hypothesis that these residues are involved in the unwinding activity of SSO0001 and supporting our assumption that the closely located large opening represents the entry gate into the SSO0001 active site (Fig. 7).
Figure 7.
Site-directed mutagenesis of SSO0001. Binding (a) and cleavage (b, c) of the 3'-[32P]-labelled ssDNA (390 nM SSO0001) or splayed arm substrate (65 nM SSO0001) by the purified wild type (wt) or mutant SSO0001 proteins. Cleavage of ssDNA was carried out for 12 minutes at 50°C, while cleavage of splayed arm substrates was for 20 minutes at 45°C. Lanes C show incubation without SSO0001 addition.
Most characterized nucleases including the RecB-like enzymes have been proposed to use a catalytic mechanism based on the two metal ion centers22. Although the apo (nonliganded) structure of the λ exonuclease showed the presence of one metal ion30, the structure of this enzyme in complex with dsDNA revealed two Mg2+ ions (MgA and MgB) bridged by the side chain of Asp119 on one side and the scissile phosphate of the DNA strand on the other29. MgA (which is present in the apo-structure) is bound to Glu129, the main chain carbonyl of Leu130, and two water molecules, one of which is also coordinated by Lys131 and is positioned for in-line attack on the scissile phosphate29 (Supplementary Fig. S8). MgB is bound only in the presence of DNA and is proposed to stabilize the transition state through the bidentate coordination to the scissile phosphate. A similar catalytic mechanism can also be proposed for SSO0001. In this model, the catalytic water molecule is coordinated by the Mn2+ ion (Supplementary Fig. 6a), Lys115, and phosphate, whereas the second metal ion (bound to Asp99), Gln131, Tyr135, and Tyr148 might interact with the DNA phosphates.
DISCUSSION
Our work together with the previous report on SSO000120 have demonstrated that Cas4 proteins represent a diverse group of metal-dependent exonucleases with 5' → 3' and 3' → 5' polarity, which also exhibit endonuclease activity against ssDNA (Fig. 1). SSO0001 also demonstrated the presence of ATP-independent DNA unwinding activity against splayed arm substrates containing both 3′- and 5′-ssDNA overhangs. Potentially, SSO0001 can use a mechanism of dsDNA processing proposed for the λ and RecE exonucleases, in which the substrate 5'-end enters the active site, whereas the 3'-end moves uncleaved through the central channel29,31. However, the structure of SSO0001 also suggests an alternative mechanism, in which DNA strands are separated at the top edge of the ring and the uncleaved 3'-ended strand is redirected out of the central channel, whereas the 5'-ended strand of dsDNA approaches the active site through the central channel. Thus, SSO0001 and other CRISPR-associated RecB-like proteins comprise a new group of RecB-like nucleases with a distinctive and complex mode of dsDNA binding, unwinding and processing.
In CRISPR interference, the Cas4 proteins have been predicted to be involved in the adaptation step together with Cas1 and Cas2 proteins which is supported by the experimental observation of in vitro complex formation between the Cas4, Cas1, and Cas2 proteins from the crenarchaeon T. tenax13. Multiple Cas4 proteins present in S. solfataricus and other genomes might have different substrate or PAM preferences or can perform different functions. A potential functional role of SSO0001 and other Cas4 proteins in CRISPR immunity is based on the presence of 5' → 3' exonuclease and DNA unwinding activities, which produce 3'-ssDNA overhangs as potential intermediates in the process of new spacer addition (Fig. 1, 2)20. Furthermore, because Cas4 proteins are likely to function in complex with Cas1 and Cas2 proteins in vivo13, the toroidal structures of SSO0001 and other Cas4 can serve as sliding clamps for other Cas proteins. Interestingly, the E. coli CRISPR system lacks a Cas4 protein, but its Cas1 protein (YgbT) has been shown to interact physically and genetically with RecB32 suggesting that the house-keeping RecB nuclease might compensate for the absence of Cas4 and contribute to CRISPR interference.
In addition to recombinational DNA repair, the E. coli RecBCD complex is involved in the protection of host cells from viral invasions through direct degradation of foreign linear DNAs15, a role which is similar to that of the CRISPR system. If the multiple active sites of the SSO0001 decameric toroid can function simultaneously, then it might represent a powerful DNA degrading machine. We hypothesize that in CRISPR interference SSO0001 and other Cas4 proteins quickly degrade viral DNA molecules using the combination of DNA unwinding and nuclease activities, whereas the host chromosomes might be protected from the degradation by other host proteins or possibly through the recognition of specific “Chi-like” sequences.
In addition, recent data suggest that the cellular role of Cas4 proteins is not limited by CRISPR interference, but they might also contribute to stress response and DNA repair. A genome-wide transcriptional study of the S. solfataricus response to UV-induced DNA damage has revealed that the expression of the SSO0001 gene is induced together with other genes involved in DNA repair33. In addition, a recent work on the T. tenax CRISPR system revealed an increased expression of its cas4 gene in UV-treated cells13. The potential role of Cas4 proteins in DNA repair might be based on their RecB-like exonuclease activity and formation of 3'-ssDNA overhangs. Together with previous works on other Cas proteins (E. coli Cas1, P. furiosus Cascade-like complex, M. jannaschii Cas7, S. solfataricus Cas8)32,34–37, these findings suggest that some components of the CRISPR system can also contribute to stress response and DNA repair, a role originally proposed for the thermophilic Cas proteins ten years ago38.
CONCLUSIONS
This study shows that the Cas4 proteins, one of the core protein families of CRISPR interference, represent a diverse group of Mg2+- or Mn2+-dependent exonucleases. The Cas4 proteins SSO0001 and Pcal_0546 belong to the DUF83 family of RecB-like proteins and cleave ssDNA with 5′ → 3′ polarity, whereas SSO1391 (DUF911) can degrade ssDNA in both directions. All three proteins also exhibit Mn2+-dependent endonuclease activity, and the presence of ATP-independent DNA unwinding activity toward dsDNA was demonstrated in SSO0001. The crystal structure of SSO0001 revealed a decameric toroid with a large 55 Å diameter central channel formed by five tightly packed “dimers”. In the SSO0001 protomer, the active site is located inside the narrow tunnel and accommodates the four RecB motif residues and one Mn2+ ion. The ten active sites of the SSO0001 toroid are open toward the central channel, which has a predominantly positively charged surface suggesting that it might serve as an entry point for the DNA substrate. Near the active site, each SSO0001 protomer contains one [4Fe-4S] cluster, which is important for both maintaining the decameric state and nuclease activity. Site-directed mutagenesis of SSO0001 revealed that the RecB motif residues (Asp99, Glu113, Lys115, and Tyr148) and four conserved Cys coordinating the Fe-S cluster (Cys32, Cys188, Cys191, and Cys197) are important for nuclease activity. In combination with the structure, this suggests a catalytic mechanism for Cas4 nucleases. We propose that the Cas4 proteins can have at least two functions in the CRISPR mechanism including the formation of 3′-overhangs for generation of new spacers, and direct degradation of foreign DNAs using a combination of DNA unwinding and nuclease activities. Future research will provide new insights into the role and molecular mechanisms of Cas4 proteins in the CRISPR/Cas system.
EXPERIMENTAL SECTION
Protein expression, purification, and mutagenesis
Cloning and purification of the 6His-tagged SSO0001, SSO1391, and Pcal_0546, as well as site-directed mutagenesis of SSO0001 were performed as described previously39. The oligomeric state of purified proteins was analyzed using size-exclusion chromatography on a Superdex 200 HiLoad 16/60 column (Amersham Biosciences) and analytical ultracentrifugation as described previously40.
Preparation of nucleic acid substrates
The ssDNA and RNA oligonucleotides used in this work (Table S1) were purchased from IDT (USA). The oligonucleotides were [32P]-labelled at the 3'-end using the calf thymus Terminal Transferase TdT or at the 5'-end using T4 polynucleotide kinase (PNK, BioLabs) and purified as previously described41. The synthetic dsDNA or splayed arm substrates were prepared by annealing the oligonucleotides shown in Tables S1 and S2. The 5′-phosphorylated and 5′-biotynilated substrates were purchased from IDT (USA).
Enzymatic and DNA binding assays
The reaction mixture for multiple-turnover ssDNase assays with SSO0001 contained 50 mM CAPS (pH 9.5), 100 mM KCl, 10 mM MgCl2 (or 0.5 mM for other divalent cations), 1 mM DTT (for exonuclease assay), 0.1 µM 3'- or 5'-[32P]-labelled substrate, or 5 nM ssDNA of the M13mp18 phage, or 20 nM pUC19 dsDNA. The reaction mixture for ssRNase assays contained 50 mM Tris-HCl (pH 7.5), 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.1 µM 3'-[32P]-labelled RNA, and SSO0001 (as indicated). The reaction mixtures for ssDNase assays with Pcal_0546 and SSO1391 contained 50 mM Tris-HCl (pH 8.0), 5 mM MgCl2 (or 2 mM of other divalent metal ion), 50 mM KCl (for SSO1391), 1 mM DTT (for exonuclease assays) and 0.1 µM 3′- or 5′-[32P]-labeled substrate (or 5 nM of M13mp18 ssDNA or 20 nM pUC19 dsDNA). The solutions were incubated at 42–50 °C and processed as previously described41. The analysis of the ssDNA product ends was carried out using T4 PNK as previously described41. The reaction for the LC-MS-based analysis of SSO0001 products was performed using optimal reaction conditions with 6 µM SSO0001 and poly-dC10 substrate (10 µg). The LC-MS analysis of the products of poly-dC10 cleavage by SSO0001 was performed using an Exactive orbitrap mass spectrometer with an electrospray ionization source and an Accela 1250 U-HPLC system (all from Thermo Scientific) essentially as previously described42. The reaction mixture for DNA-binding assays contained 50 mM Tris-HCl (pH 8.0), 5 mM KCl, 0.5 mM CaCl2, 1 mM DTT, and SSO0001 (as indicated). The solutions were incubated at 25 °C for 10 min and analyzed by native gel electrophoresis (10% acrylamide). These reaction conditions are optimal for DNA binding, whereas the DNA cleavage was prevented by low incubation temperature, short incubation time, and Ca2+ ions.
Crystallization and structure determination of SSO0001
SSO0001 was crystallized at room temperature using the sitting drop vapour diffusion protocol by mixing 1 µl of the selenomethionine substituted protein (10 mg/ml) with 1 µl of the crystallization solution containing 25 % (w/v) PEG 2000 MME, 0.2 M NaCl, 100 mM Na-acetate (pH 5.6), and 0.3 M NDSB 201. The crystals were stabilized with the crystallization buffer containing 3 M NaCl followed by cryoprotection in Paratone-N prior to flash-freezing in liquid nitrogen. Data collections were carried out at the beamlines 19-ID and 19-BM of the Structural Biology Center, Advanced Photon Source, Argonne National Laboratory43. Prior to data collection, an X-ray fluorescence spectrum was recorded, which identified the presence of Se, Fe, and Mn in protein crystals. Data set was collected from a single crystal to 2.35 Å at the wavelength of 0.9794-Å and processed using the program HKL300044 (Table S3). The structure of SSO0001 was determined by the Se-methionine SAD phasing, density modification, and initial model building as implemented in the Auto-Rickshaw package45. The initial models (~60% complete) were further built manually using the program COOT46 and refined with the PHENIX47 and REFMAC48 programs. The presence and identity of metals were verified by collecting data sets (from the same crystal) at the iron X-ray K absorption edge and just above the Mn absorption edge and calculating anomalous Fourier difference maps (Supplementary Fig. S6). Analysis and validation of structures were performed using MOLPROBITY49 and COOT46 validation tools. The final model was refined to Rwork/Rfree = 0.205/0.249, and it shows good geometry with no outliers in the Ramachandran plot. Data collection and refinement statistics are summarized in Supplementary Table S3. The atomic coordinates have been deposited in the Protein Data Bank, with accession code 4IC1.
Supplementary Material
ACKNOWLEDGMENTS
We thank all members of the Structural Proteomics in Toronto (SPiT) Centre and the Structural Biology Center at Argonne National Laboratory (especially Frank Rotella) for help in conducting the experiments. Dr. David Bernick (University of California, Santa Cruz) is thanked for sending the Pyrobaculum calidifontis genomic DNA. This work was supported by the Government of Canada through Genome Canada and Ontario Genomics Institute (2009-OGI-ABC-1405), Ontario Research Fund (ORF-GL2-01-004), Natural Science and Engineering Research Council of Canada, and in part by a grant from the National Institutes of Health Grant GM094585 and by the U.S. Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357.
Footnotes
ASSOCIATED CONTENT
Supporting Information
Supplementary experimental and structural data presented in eight supplementary figures and three supplementary tables. This material is available free of charge via the Internet at http://pubs.acs.org.
The authors declare no competing financial interest.
REFERENCES
- 1.Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV. Biol Direct. 2006;1:7. doi: 10.1186/1745-6150-1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, Moineau S, Mojica FJ, Wolf YI, Yakunin AF, van der Oost J, Koonin EV. Nat Rev Microbiol. 2011;9:467. doi: 10.1038/nrmicro2577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wiedenheft B, Sternberg SH, Doudna JA. Nature. 2012;482:331. doi: 10.1038/nature10886. [DOI] [PubMed] [Google Scholar]
- 4.Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, Wells L, Terns RM, Terns MP. Cell. 2009;139:945. doi: 10.1016/j.cell.2009.07.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Westra ER, Swarts DC, Staals RH, Jore MM, Brouns SJ, van der Oost J. Annu Rev Genet. 2012;46:311. doi: 10.1146/annurev-genet-110711-155447. [DOI] [PubMed] [Google Scholar]
- 6.Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. Science. 2008;321:960. doi: 10.1126/science.1159689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. Science. 2012;337:816. doi: 10.1126/science.1225829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadan AH, Moineau S. Nature. 2010;468:67. doi: 10.1038/nature09523. [DOI] [PubMed] [Google Scholar]
- 9.Haft DH, Selengut J, Mongodin EF, Nelson KE. PLoS Comput Biol. 2005;1:e60. doi: 10.1371/journal.pcbi.0010060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sorek R, Lawrence CM, Wiedenheft B. Annu Rev Biochem. 2013 doi: 10.1146/annurev-biochem-072911-172315. [DOI] [PubMed] [Google Scholar]
- 11.Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. Science. 2007;315:1709. doi: 10.1126/science.1138140. [DOI] [PubMed] [Google Scholar]
- 12.Fineran PC, Charpentier E. Virology. 2012;434:202. doi: 10.1016/j.virol.2012.10.003. [DOI] [PubMed] [Google Scholar]
- 13.Plagens A, Tjaden B, Hagemann A, Randau L, Hensel R. J Bacteriol. 2012;194:2491. doi: 10.1128/JB.00206-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kinch LN, Ginalski K, Rychlewski L, Grishin NV. Nucleic Acids Res. 2005;33:3598. doi: 10.1093/nar/gki676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM. Microbiol Rev. 1994;58:401. doi: 10.1128/mr.58.3.401-465.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Singleton MR, Dillingham MS, Gaudier M, Kowalczykowski SC, Wigley DB. Nature. 2004;432:187. doi: 10.1038/nature02988. [DOI] [PubMed] [Google Scholar]
- 17.Saikrishnan K, Yeeles JT, Gilhooly NS, Krajewski WW, Dillingham MS, Wigley DB. EMBO J. 2012;31:1568. doi: 10.1038/emboj.2012.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Garrett RA, Shah SA, Vestergaard G, Deng L, Gudbergsdottir S, Kenchappa CS, Erdmann S, She Q. Biochem Soc Trans. 2011;39:51. doi: 10.1042/BST0390051. [DOI] [PubMed] [Google Scholar]
- 19.Gudbergsdottir S, Deng L, Chen Z, Jensen JV, Jensen LR, She Q, Garrett RA. Mol Microbiol. 2011;79:35. doi: 10.1111/j.1365-2958.2010.07452.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang J, Kasciukovic T, White MF. PLoS One. 2012;7:e47232. doi: 10.1371/journal.pone.0047232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wang J, Chen R, Julin DA. J Biol Chem. 2000;275:507. doi: 10.1074/jbc.275.1.507. [DOI] [PubMed] [Google Scholar]
- 22.Yang W. Q Rev Biophys. 2011;44:1. doi: 10.1017/S0033583510000181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Little JW. J Biol Chem. 1967;242:679. [PubMed] [Google Scholar]
- 24.Pingoud A, Fuxreiter M, Pingoud V, Wende W. Cell Mol Life Sci. 2005;62:685. doi: 10.1007/s00018-004-4513-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Almendros C. Microbiology. 2009;155:733. doi: 10.1099/mic.0.023960-0. [DOI] [PubMed] [Google Scholar]
- 26.Yeeles JT, Cammack R, Dillingham MS. J Biol Chem. 2009;284:7746. doi: 10.1074/jbc.M808526200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Holm L, Rosenstrom P. Nucleic Acids Res. 2010;38:W545. doi: 10.1093/nar/gkq366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yang W, Chen WY, Wang H, Ho JW, Huang JD, Woo PC, Lau SK, Yuen KY, Zhang Q, Zhou W, Bartlam M, Watt RM, Rao Z. Nucleic Acids Res. 2011;39:9803. doi: 10.1093/nar/gkr660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Zhang J, McCabe KA, Bell CE. Proc Natl Acad Sci U S A. 2011;108:11872. doi: 10.1073/pnas.1103467108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kovall R, Matthews BW. Science. 1997;277:1824. doi: 10.1126/science.277.5333.1824. [DOI] [PubMed] [Google Scholar]
- 31.Zhang J, Xing X, Herr AB, Bell CE. Structure. 2009;17:690. doi: 10.1016/j.str.2009.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Babu M, Beloglazova N, Flick R, Graham C, Skarina T, Nocek B, Gagarinova A, Pogoutse O, Brown G, Binkowski A, Phanse S, Joachimiak A, Koonin EV, Savchenko A, Emili A, Greenblatt J, Edwards AM, Yakunin AF. Mol Microbiol. 2011;79:484. doi: 10.1111/j.1365-2958.2010.07465.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Frols S, Gordon PM, Panlilio MA, Duggin IG, Bell SD, Sensen CW, Schleper C. J Bacteriol. 2007;189:8708. doi: 10.1128/JB.01016-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Boonyaratanakornkit BB, Miao LY, Clark DS. Extremophiles. 2007;11:495. doi: 10.1007/s00792-007-0063-4. [DOI] [PubMed] [Google Scholar]
- 35.Gotz D, Paytubi S, Munro S, Lundgren M, Bernander R, White MF. Genome Biol. 2007;8:R220. doi: 10.1186/gb-2007-8-10-r220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Strand KR, Sun C, Li T, Jenney FE, Jr, Schut GJ, Adams MW. Arch Microbiol. 2010;192:447. doi: 10.1007/s00203-010-0570-z. [DOI] [PubMed] [Google Scholar]
- 37.Williams E, Lowe TM, Savas J, DiRuggiero J. Extremophiles. 2007;11:19. doi: 10.1007/s00792-006-0002-9. [DOI] [PubMed] [Google Scholar]
- 38.Makarova KS, Aravind L, Grishin NV, Rogozin IB, Koonin EV. Nucleic Acids Res. 2002;30:482. doi: 10.1093/nar/30.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Beloglazova N, Brown G, Zimmerman MD, Proudfoot M, Makarova KS, Kudritska M, Kochinyan S, Wang S, Chruszcz M, Minor W, Koonin EV, Edwards AM, Savchenko A, Yakunin AF. J Biol Chem. 2008;283:20361. doi: 10.1074/jbc.M803225200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Snider J, Gutsche I, Lin M, Baby S, Cox B, Butland G, Greenblatt J, Emili A, Houry WA. J Biol Chem. 2006;281:1532. doi: 10.1074/jbc.M511172200. [DOI] [PubMed] [Google Scholar]
- 41.Beloglazova N, Petit P, Flick R, Brown G, Savchenko A, Yakunin AF. EMBO J. 2011;30:4616. doi: 10.1038/emboj.2011.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lu W, Clasquin MF, Melamud E, Amador-Noguez D, Caudy AA, Rabinowitz JD. Anal Chem. 2010;82:3212. doi: 10.1021/ac902837x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Rosenbaum G, Alkire RW, Evans G, Rotella FJ, Lazarski K, Zhang RG, Ginell SL, Duke N, Naday I, Lazarz J, Molitsky MJ, Keefe L, Gonczy J, Rock L, Sanishvili R, Walsh MA, Westbrook E, Joachimiak A. J Synchrotron Radiat. 2006;13:30. doi: 10.1107/S0909049505036721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. Acta Crystallogr D Biol Crystallogr. 2006;62:859. doi: 10.1107/S0907444906019949. [DOI] [PubMed] [Google Scholar]
- 45.Panjikar S, Parthasarathy V, Lamzin VS, Weiss MS, Tucker PA. Acta Crystallogr D Biol Crystallogr. 2005;61:449. doi: 10.1107/S0907444905001307. [DOI] [PubMed] [Google Scholar]
- 46.Emsley P, Cowtan K. Acta Crystallogr D Biol Crystallogr. 2004;60:2126. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 47.Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. Acta Crystallogr D Biol Crystallogr. 2010;66:213. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Murshudov GN, Vagin AA, Dodson EJ. Acta Crystallogr D Biol Crystallogr. 1997;53:240. doi: 10.1107/S0907444996012255. [DOI] [PubMed] [Google Scholar]
- 49.Davis IW, Murray LW, Richardson JS, Richardson DC. Nucleic Acids Res. 2004;32:W615. doi: 10.1093/nar/gkh398. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







